Cystic fibrosis - elexacaftor+tezacaftor+ivacaftor - initial authority application form (PB286)

Use this form to apply for initial PBS-subsidised treatment with elexacaftor+tezacaftor+ivacaftor for patients at least 2 years of age with cystic fibrosis.

Page last updated: 1 June 2025.
QC 51931